AlphaFold predicted structure
SYN1 · P17600

Mean pLDDT
68.1/ 100
Low
705 residues
Confidence breakdown
- Very high(≥ 90)41%
- Confident(70–90)5%
- Low(50–70)8%
- Very low(< 50)45%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
synapsin I
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesEarly onset or syndromic epilepsy
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)Intellectual disability
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesFetal anomalies
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesepilepsy, X-linked 1, with variable learning disabilities and behavior disorders
X-linked epilepsy - learning disabilities - behavior disorders
X-linked non-syndromic intellectual disability
hereditary disease
X-linked complex neurodevelopmental disorder
epilepsy
Seizure
Intellectual disability
autism spectrum disorder
Alzheimer disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Synapsin-1
Neuronal phosphoprotein that coats synaptic vesicles, and binds to the cytoskeleton. Acts as a regulator of synaptic vesicles trafficking, involved in the control of neurotransmitter release at the pre-synaptic terminal (PubMed:21441247, PubMed:23406870). Also involved in the regulation of axon outgrowth and synaptogenesis (By similarity). The complex formed with NOS1 and CAPON proteins is necessary for specific nitric-oxid functions at a presynaptic level (By similarity)
SYN1 · P17600

Mean pLDDT
68.1/ 100
Low
705 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0